TreeActiv Cystic Acne Spot Treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TreeActiv Cystic Acne Spot Treatment
Generic name: SULFUR
Manufacturer: Leiluna LLC
Product type: HUMAN OTC DRUG
SPL set ID: d1b81650-ccc4-49ed-9378-726b3a3a04c7
SPL ID: f9116ba0-b9be-4c3c-be76-8b9a6427e739
Version: 4
Effective date: 2025-04-08
Source export date: 2026-10-12
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:18:14

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		TreeActiv Cystic Acne Spot Treatment	openfda.brand_name
generic name		SULFUR	openfda.generic_name
manufacturer name		Leiluna LLC	openfda.manufacturer_name
ndc	package	72841-201-01	openfda.package_ndc
ndc	package	72841-201-02	openfda.package_ndc
ndc	product	72841-201	openfda.product_ndc
ndc11	package	72841020101	derived:openfda.package_ndc
ndc11	package	72841020102	derived:openfda.package_ndc
rxcui		2636729	openfda.rxcui
spl id		f9116ba0-b9be-4c3c-be76-8b9a6427e739	id
spl set id		d1b81650-ccc4-49ed-9378-726b3a3a04c7	set_id
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only. Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Do not get into eyes. If excessive skin irritation develops or increases, discontinue use and consult a doctor. Apply to affected areas only. Do not use on broken skin or apply to large areas of the body. KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.